Skip to main content

Table 1 Patient characteristics of the whole study population devided by BMI quartiles

From: Obesity-associated hypertension is ameliorated in patients with TLR4 single nucleotide polymorphism (SNP) rs4986790

 

Whole Cohort (n = 3017)

BMI, quartiles

Q1

Q2

Q3

Q4

Number, n (%)

754 (25)

756 (25)

752 (25)

755 (25)

Age, y

56,6 ± 9,5

57,6 ± 9,1

57,0 ± 8,5

57,1 ± 8,9

Sex, female,n (%)

272 (36)

142 (19)

158 (21)

209 (28)

BMI, kg/m2

22,6 ± 1,7

25,8 ± 0.7

28,1 ± 0.8

32,7 ± 3,1*

Smoking, n (%)

344 (46)

355 (47)

362 (48)

345 (46)

Diabetes, n (%)

90 (12)

93 (12)

85 (11)

145 (19)*

Hypercholesterolemia, n (%)

387 (51)

444 (59)

420 (56)

450 (60)*

LDL, mg/dl

122,6 ± 39,9

126,3 ± 40,3

125,5 ± 41,3

122,4 ± 40,5

HDL, mg/dl

55,3 ± 31,8

49,5 ± 16,0

46,9 ± 15,6

45,3 ± 13,0*

TG, mg/dl

134,8 ± 132,1

157,6 ± 111,2

169,8 ± 106.4

198,2 ± 192,1*

SBP, mmHg

144,5 ± 26,8

144,9 ± 25,6

145,2 ± 25,4

147,8 ± 26,2*

DBP, mmHg

79,5 ± 3,6

79,6 ± 3,7

79,5 ± 3,8

79,7 ± 3,6

PP, mmHg

64,7 ± 26,8

65,6 ± 25,4

65,8 ± 24,9

68,1 ± 26,2*

Hypertension, n (%)

401 (53)

429 (57)

426 (57)

(454) 60*

Antihypertensive drugs, n

1,14 ± 1.07

1,26 ± 1,07

1,31 ± 1,06

1,46 ± 1,09*

HR, bpm

75,3 ± 12,5

73,5 ± 12,6

73,7 ± 12,3

73,6 ± 12,6

MI, n (%)

494 (66)

561 (74)

548 (73)

530 (70)

  1. Data are presented as mean ± SD; other variables are presented as number (%), Q1-Q4: quartile 1-4, BMI quartile ranges: Q1: BMI < 24,64, Q2: BMI ≥24.65-26,89, Q3: BMI ≥ 26. 26.90-29.50, Q4: BMI ≥ 29,51; BMI body mass index, LDL low-density lipoprotein, HDL high-density lipoprotein, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, PP pulse pressure, HR heart rate, MI myocardial infarction; *P for trend <0.05